Serum adropin levels are decreased in patients with acute myocardial infarction

Regulatory Peptides

Volumn 190-191, Issue , 2014, Pages 46-49

  Yu, Hou you ^a   Zhao, Peng ^a   Wu, Ming chun ^b   Liu, Jian ^a   Yin, Wen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Acute myocardial infarction; Adropin; Atherosclerosis; Biomarkers; Coronary artery disease

Indexed keywords

ADROPIN; BIOLOGICAL MARKER; REGULATOR PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ENHO PROTEIN, HUMAN; PEPTIDE; PLASMA PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STABLE ANGINA PECTORIS; ANGINA PECTORIS; BLOOD; HEART INFARCTION; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL;

ANGINA;

ANGINA PECTORIS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PEPTIDES;

EID: 84902115646     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2014.04.001     Document Type: Article

References (17)

1. Pope J.H., Aufderheide T.P., Ruthazer R., Woolard R.H., Feldman J.A., Beshansky J.R., et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000, 342:1163-1170.
2. Swap C.J., Nagurney J.T. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. JAMA 2005, 294:2623-2629.
3. Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113:2335-2362.
4. Kumar K.G., Trevaskis J.L., Lam D.D., Sutton G.M., Koza R.A., Chouljenko V.N., et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 2008, 8:468-481.
5. Lovren F., Pan Y., Quan A., Singh K.K., Shukla P.C., Gupta M., et al. Adropin is a novel regulator of endothelial function. Circulation 2010, 122:S185-S192.
6. Kathir K., Adams M.R. Endothelial dysfunction as a predictor of acute coronary syndromes. Semin Vasc Med 2003, 3:355-362.
7. Wu L., Fang J., Chen L., Zhao Z., Luo Y., Lin C., et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med 2014, 52:751-758.
8. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. Circulation 2012, 126:2020-2035.
9. Lian W., Gu X., Qin Y., Zheng X. Elevated plasma levels of adropin in heart failure patients. Intern Med 2011, 50:1523-1527.
10. Mattu H.S., Randeva H.S. Role of adipokines in cardiovascular disease. J Endocrinol 2013, 216:T17-T36.
11. Aydin S., Kuloglu T., Aydin S., Eren M.N., Yilmaz M., Kalayci M., et al. Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol Cell Biochem 2013, 380:73-81.
12. Gozal D., Kheirandish-Gozal L., Bhattacharjee R., Molero-Ramirez H., Tan H.L., Bandla H.P. Circulating adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function. J Pediatr 2013, 163:1122-1126.
13. Ignarro L.J. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 2002, 53:503-514.
14. Alp N.J., Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004, 24:413-420.
15. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.
16. Butler A.A., Tam C.S., Stanhope K.L., Wolfe B.M., Ali M.R., O'Keeffe M., et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab 2012, 97:3783-3791.
17. Martin M.W. Treatment of congestive heart failure a neuroendocrine disorder. J Small Anim Pract 2003, 44:154-160.